632 followers
Comparison of effectiveness and safety of camrelizumab between HBV-related and non-B, non-C hepatocellular carcinoma: A retrospective study in China https://t.co/J7CgUGl9h5
Comparison of effectiveness and safety of camrelizumab between HBV-related and non-B, non-C hepatocellular carcinoma: A retrospective study in China https://t.co/J7CgUGl9h5
New Research: Comparison of effectiveness and safety of camrelizumab between HBV-related and non-B, non-C hepatocellular carcinoma: A retrospective study in China: Purpose: This study aimed to compare the clinical outcomes of camrelizumab in… https://t.co/